Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-06-04
2011-10-11
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S258000
Reexamination Certificate
active
08034816
ABSTRACT:
Disclosed are hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, processes for preparing them and their use as pharmaceutical compositions.
REFERENCES:
patent: 4957922 (1990-09-01), Lammens et al.
patent: 5167949 (1992-12-01), Ferrand et al.
patent: 5198547 (1993-03-01), Bailey et al.
patent: 5424311 (1995-06-01), Billhardt-Troughton et al.
patent: 5698556 (1997-12-01), Chan
patent: 6096924 (2000-08-01), Studer et al.
patent: 6156766 (2000-12-01), Arita et al.
patent: 6174895 (2001-01-01), Kleinman
patent: 6605255 (2003-08-01), Kroll et al.
patent: 6806272 (2004-10-01), Bauer et al.
patent: 6861422 (2005-03-01), Hoffmann et al.
patent: 6875868 (2005-04-01), Bonnert et al.
patent: 7238807 (2007-07-01), Duran et al.
patent: 7241889 (2007-07-01), Hoffmann et al.
patent: 7332491 (2008-02-01), Grauert et al.
patent: 7371753 (2008-05-01), Stadtmueller et al.
patent: 7414053 (2008-08-01), Grauert et al.
patent: 7439358 (2008-10-01), Linz et al.
patent: 7547780 (2009-06-01), Grauert et al.
patent: 7625899 (2009-12-01), Hoffmann et al.
patent: 7626019 (2009-12-01), Duran et al.
patent: 7629460 (2009-12-01), Grauert et al.
patent: 7700769 (2010-04-01), Grauert et al.
patent: 7723517 (2010-05-01), Grauert et al.
patent: 7728134 (2010-06-01), Linz et al.
patent: 7750152 (2010-07-01), Hoffman et al.
patent: 7759347 (2010-07-01), Hoffmann
patent: 7759485 (2010-07-01), Linz et al.
patent: 7807831 (2010-10-01), Grauert et al.
patent: 7816530 (2010-10-01), Grauert
patent: 2002/0183292 (2002-12-01), Pairet et al.
patent: 2002/0183293 (2002-12-01), Banerjee et al.
patent: 2003/0130286 (2003-07-01), Denny et al.
patent: 2004/0029885 (2004-02-01), Bauer et al.
patent: 2004/0147524 (2004-07-01), Bauer et al.
patent: 2004/0176380 (2004-09-01), Hoffmann et al.
patent: 2005/0014760 (2005-01-01), Hoffmann et al.
patent: 2005/0014761 (2005-01-01), Hoffmann et al.
patent: 2005/0148501 (2005-07-01), Palmer et al.
patent: 2005/0159414 (2005-07-01), Nickolaus et al.
patent: 2005/0165010 (2005-07-01), Nickolaus et al.
patent: 2006/0004014 (2006-01-01), Hoffmann et al.
patent: 2006/0009457 (2006-01-01), Hoffmann et al.
patent: 2006/0025411 (2006-02-01), Hoffmann et al.
patent: 2006/0035902 (2006-02-01), Linz et al.
patent: 2006/0035903 (2006-02-01), Mohr et al.
patent: 2006/0046989 (2006-03-01), Grauert et al.
patent: 2006/0047118 (2006-03-01), Stadtmueller et al.
patent: 2006/0052383 (2006-03-01), Grauert et al.
patent: 2006/0058311 (2006-03-01), Munzert et al.
patent: 2006/0074088 (2006-04-01), Munzert et al.
patent: 2006/0079503 (2006-04-01), Schwede et al.
patent: 2007/0208027 (2007-09-01), Duran et al.
patent: 2007/0213528 (2007-09-01), Duran et al.
patent: 2007/0213529 (2007-09-01), Duran et al.
patent: 2007/0213530 (2007-09-01), Duran et al.
patent: 2007/0213531 (2007-09-01), Duran et al.
patent: 2007/0213534 (2007-09-01), Duran et al.
patent: 2007/0219369 (2007-09-01), Duran et al.
patent: 2008/0108812 (2008-05-01), Grauert et al.
patent: 2008/0113992 (2008-05-01), Grauert et al.
patent: 2008/0171747 (2008-07-01), Hoffman et al.
patent: 2008/0177066 (2008-07-01), Linz et al.
patent: 2008/0194818 (2008-08-01), Grauert et al.
patent: 2008/0221099 (2008-09-01), Munzert et al.
patent: 2008/0293944 (2008-11-01), Hoffmann et al.
patent: 2008/0319190 (2008-12-01), Grauert et al.
patent: 2008/0319192 (2008-12-01), Grauert et al.
patent: 2008/0319193 (2008-12-01), Grauert et al.
patent: 2009/0018333 (2009-01-01), Grauert et al.
patent: 2009/0023733 (2009-01-01), Cage et al.
patent: 2009/0030004 (2009-01-01), Linz et al.
patent: 2009/0124628 (2009-05-01), Hoffmann et al.
patent: 2009/0143379 (2009-06-01), Mohr et al.
patent: 2009/0238828 (2009-09-01), Munzert et al.
patent: 2009/0280115 (2009-11-01), Maier et al.
patent: 2009/0298840 (2009-12-01), Linz et al.
patent: 2010/0029642 (2010-02-01), Hoffmann et al.
patent: 2010/0249412 (2010-09-01), Linz et al.
patent: 2010/0249458 (2010-09-01), Linz et al.
patent: 2010/0280037 (2010-11-01), Linz et al.
patent: 2010/0324288 (2010-12-01), Hoffmann et al.
patent: 2458699 (2003-03-01), None
patent: 2517020 (2004-09-01), None
patent: 2517010 (2004-11-01), None
patent: 2576290 (2006-02-01), None
patent: 143478 (1985-06-01), None
patent: 347146 (1989-12-01), None
patent: 399856 (1990-11-01), None
patent: 429149 (1991-05-01), None
patent: 2287583 (2007-12-01), None
patent: 2002125451 (2004-01-01), None
patent: 9609045 (1996-03-01), None
patent: 9634867 (1996-11-01), None
patent: 9636597 (1996-11-01), None
patent: 9811893 (1998-03-01), None
patent: 0119825 (2001-03-01), None
patent: 0170741 (2001-09-01), None
patent: 0178732 (2001-10-01), None
patent: 02057261 (2002-07-01), None
patent: 02076954 (2002-10-01), None
patent: 02076985 (2002-10-01), None
patent: 03020722 (2003-03-01), None
patent: 03093249 (2003-11-01), None
patent: 2004014899 (2004-02-01), None
patent: 2004076454 (2004-09-01), None
patent: 2004093848 (2004-11-01), None
patent: 2005067935 (2005-07-01), None
patent: 2006/018182 (2006-02-01), None
patent: 2006/018221 (2006-02-01), None
patent: 2006018185 (2006-02-01), None
patent: 2006018220 (2006-02-01), None
patent: 2006018221 (2006-02-01), None
patent: 2006021378 (2006-03-01), None
patent: 2007090844 (2007-08-01), None
patent: 2009019205 (2009-02-01), None
ACPS Meeting, Background Information. “Scientific considerations of plymorphism in pharmaceutical solids: abbreviated new drug applications”. Oct. 2002.
Ahlenius, T. List of cardiovascular disorder/diseases. Ahlenius, Karolinska Institutet. Stockholm, Sweden. Cardiovascular Diseases, p. 1-34, Apr. 2007.
Ahmad, N. “Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer”. Dept of Dermatology, Univ. Wisconsin, pp. 3-5, 2003.
Arnold, K. “Collaboration to play key role in NCI's future, director says”. Journal of the National Cancer Institute, Jun. 5, 2002, pp. 790-792, vol. 94, No. 11.
BBC News/Health, Killer Breast Cancern Therapy Hope, www.newsvote.bbc/co./uk, downloaded Mar. 26, 2009.
Bennett, J.C., et al., “Textbook of Medicine”, Part XIV, Oncology, 1997.
Blain, S. W. et al., “Differential interaction of the cyclin-dependent kinase (Cdk) Inhibitor p27KIP with cyclin A-Cdk2 and cyclin D2-Cdk4”. The Journal of Biological Chemistry, vol. 272, No. 41, Issue Oct. 10, 1997, pp. 25862-25872.
Dipolar aprotic solvent. Exhibit A, IUPAC Compendium of Chemical Terminology, 2nd Edition, 1997.
Doerwald, F.Z. “Side reactions in organice synthesis”. 2005.
Eurasian Opinion, Appln No. 2007/00389/28, Maly Slatoustinsky per., d.10, kv.15, 101000 Moscow, Russia, “EVROMARKPAT”, 2007.
Ferrand, G., et al., “Synthesis and potential antiallergic activity of new pteridinones and related compounds”. Eur. J. Med. Chem, 31, 1996, pp. 273-280. XP—2246920.
Giron, G. “Thernal analysis and calorimetric methods in the characterization of plymorphs and solvates”. Thermochimica Acta 248, 1995, pp. 1-59.
Goodman-Gilman's “The Pharmacological Basis of Therapeutics”. Ninth edition, 1996, pp. 1225-1271.
Ito, Y., et al., “Polo-like kinase 1 (PLK) expression is associated with cell proliferative activity and cdc2 expression in malignant-lymphoma of the thyroid”. Anticancer Research, 2004, vol. 24, No. 1, pp. 259-263.
Jaworska, J., et al., “Review of methods for assessing the applicability domains of SARS and QSARS”. Sponsor: The European Commission—Joint Research Ctr., Institute for Health and Consumer Protection—ECVAM, Italy, 2004.
Kashima, M. K. et al., “Expression of polo-like kinase (PLK1) in non-Hodgkin's lymphomas”. NCBI, PubMed, 2005.
Kimball, S. D. et al., “Cell cycle kinases and checkpoint regulation in cancer”. Annual Reports in Medicinal Chemistry, 36, Chapter 14, pp. 139-148, 2001.
Leukemia & Lymphoma Society—Disease Information-Lymphoma. www.leukemia-lymphoma.org/all—page?item&#
Herter Rolf
Hoffmann Matthias
Kraemer Gerd F.
Linz Guenter
Rall Werner
Boehringer Ingelheim International GmbH
Jaisle Cecilia M
Morris Michael P.
Scott Julie A.
Wilson James O
LandOfFree
Hydrates and polymorphs of 4-[[(7 R... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrates and polymorphs of 4-[[(7 R..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrates and polymorphs of 4-[[(7 R... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4284294